Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.

@article{Hata2002UseOA,
  title={Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants.},
  author={Atsuko Hata and Hideomi Asanuma and Mary M. Rinki and Margaret Sharp and Ruby M Wong and Karl Blume and Ann Margaret Arvin},
  journal={The New England journal of medicine},
  year={2002},
  volume={347 1},
  pages={26-34}
}
BACKGROUND The reactivation of varicella-zoster virus from latency causes zoster and is common among recipients of hematopoietic-cell transplants. METHODS We randomly assigned patients who were scheduled to undergo autologous hematopoietic-cell transplantation for non-Hodgkin's or Hodgkin's lymphoma to receive varicella vaccine or no vaccine. Heat-inactivated, live attenuated varicella vaccine was given within 30 days before transplantation and 30, 60, and 90 days after transplantation. The… CONTINUE READING
86 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 86 extracted citations

Similar Papers

Loading similar papers…